What is Biotechnology?

 

What is Biotechnology?


Biotechnology is technology that uses biological systems, or parts of these organisms to develop or create different product life.

Brewing and baking bread are examples of processes that fall within the concept of biotechnology (the use of yeast (= a living organism) to produce the desired product). typically utilize traditional processes such as living organisms in their natural form (or further developed by breeding), whereas a more modern form of biotechnology generally will involve more advanced modification of biological systems or organisms.

With the development of genetic engineering in the 1970s, research in the field of biotechnology (and other related fields such as medicine, biology, etc.) are growing rapidly because of new possibilities to make changes in an organism's genetic material (DNA).

usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio usabio


Today, biotechnology includes a range of disciplines (eg, genetics, biochemistry, molecular biology, etc.). new technology and products developed every year in the field, for example. medicine (the development of new drugs and therapies), agriculture (development of genetically modified crops, biofuels, biological treatment) or biotechnology industry (production of chemicals, paper, textiles and food).

Comments

Post a Comment

Popular posts from this blog

Safety and activity of anti-PD-L1 antibody in patients with advanced cancer

 BACKGROUND The fixed die 1 (PD-1) protein, T-cell receptor coinhibitory, and one of the ligands, PD-L1, plays an important role in the ability of tumor cells to evade the host immune system. Blockade of the interaction between PD-1 and PD-L1 enhance immune function in vitro and mediate antitumor activity in preclinical models. METHOD In the multicenter Phase 1 trial, we are given an intravenous anti-PD-L1 antibody (in increasing doses ranging from 0.3 to 10 mg per kilogram of body weight) for patients with advanced cancer were selected. Anti-PD-L1 antibody was given every 14 days in 6-week cycles to 16 cycles or until the patient had a complete response or confirmed disease progression. RESULTS As of February 24, 2012, a total of 207 patients - 75 with lung cancer non-small cell, 55 with melanoma, 18 with colorectal cancer, 17 with renal cell cancer, 17 with ovarian cancer, 14 with pancreatic cancer, 7 with gastric cancer and 4 with breast cancer - has received an anti-PD-L1 antibody.
Read more

The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and labeled antibody (PAP) procedures

 The use of avidin-biotin interaction in immunoenzymatic technique provides a simple and sensitive method for localizing antigens in formalin-fixed tissue. Among some staining procedures are available, the ABC method, which involves the application of biotin-labeled secondary antibodies followed by the addition of avidin-biotin-peroxidase complex, providing superior results when compared to the labeled antibody method. Availability of biotin-binding sites within the complex made by incubation of the relative merits of peroxidase labeled avidin with biotin. During complex formation, acts as a bridge between the labeled avidin biotin peroxidase molecule; and biotin-peroxidase labeled molecules, which contain multiple clusters of biotin, serves as a liaison between avidin molecules. As a result, "grid" which contains some peroxidase complex molecules may have formed. This complex binding to the biotin groups associated with secondary antibody results in a high staining intensity
Read more